Kim Ellefsen-Lavoie

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

University of Lausanne(Current)

University Hospital of Lausanne

Kim Ellefsen-Lavoie is an author at University of Lausanne specializing in cellular immune response to viruses, veterinary medicine, and immune response to vaccination.

Publications per year

2018–2020

Publications

Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometry

Evelina Cardoso, Thomas Mercier, Dorothea Wagner et al. · Journal of Chromatography B · 2018 · 43 citations

Medicine, Oncology, Pharmacology +13

Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial

Yves Lévy, Christine Lacabaratz, Kim Ellefsen-Lavoie et al. · PLoS Pathogens · 2020 · 14 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

1–2 of 2